Algert Global’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-19,873
| Closed | -$57K | – | 1343 |
|
|
2021
Q4 | $57K | Sell |
19,873
-15,213
| -43% | -$43.6K | 0.01% | 934 |
|
|
2021
Q3 | $149K | Buy |
35,086
+9,368
| +36% | +$39.8K | 0.02% | 945 |
|
|
2021
Q2 | $136K | Buy |
25,718
+4,940
| +24% | +$26.1K | 0.05% | 381 |
|
|
2021
Q1 | $97K | Hold |
20,778
| – | – | 0.03% | 413 |
|
|
2020
Q4 | $69K | Sell |
20,778
-30,250
| -59% | -$100K | 0.02% | 390 |
|
|
2020
Q3 | $169K | Buy |
51,028
+9,880
| +24% | +$32.7K | 0.05% | 331 |
|
|
2020
Q2 | $139K | Buy |
41,148
+9,142
| +29% | +$30.9K | 0.05% | 358 |
|
|
2020
Q1 | $123K | Buy |
+32,006
| New | +$123K | 0.05% | 344 |
|